Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $140.00
05:02am, Monday, 27'th Jul 2020
BioMarin Pharmaceutical (NASDAQ:BMRN) had its price objective boosted by Robert W. Baird from $125.00 to $140.00 in a research report released on Friday, The Fly reports. Other equities research analy
3 Unstoppable Stocks to Buy Before the Next Market Crash
11:30am, Saturday, 25'th Jul 2020
The healthcare industry is a good place to shop for stocks to keep your portfolio healthy during the next market crash.
3 Biotech Stocks With Big Incoming Catalysts
10:56am, Saturday, 25'th Jul 2020
Biotech investors can get ready for a busy month full of stock-moving binary events. All of these companies are waiting for the FDA to make some very important approval decisions. Here's what you sh
3 Unstoppable Stocks to Buy Before the Next Market Crash
07:30am, Saturday, 25'th Jul 2020
The healthcare industry is a good place to shop for stocks to keep your portfolio healthy during the next market crash.
3 Biotech Stocks With Big Incoming Catalysts
06:56am, Saturday, 25'th Jul 2020
Binary events could send shares of these stocks screaming higher, or lower, soon.
Rising Risk? Here's What You Can Buy
03:21pm, Friday, 24'th Jul 2020
Volatility caused by dismal economic data creates opportunities. Our overbought reading is heating up, suggesting you proactively pick entry points.
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
11:15am, Friday, 24'th Jul 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 23) * Abbott Laboratories (NYSE: ABT) * ABIOMED, Inc. (NASDAQ: ABMD) * Acceleron Pharma Inc (NASDAQ: XLRN) * Aerpio Pharmaceuticals Inc (NA
Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks
10:51am, Friday, 24'th Jul 2020
The health care sector has been a big winner in 2020, far outpacing the Dow Jones industrial average and S&P 500.
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Vosoritide to Treat Children with Achondroplasia
08:07pm, Thursday, 23'rd Jul 2020
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for vosoritide, an investigati
Freeline Therapeutics Aims For $100 Million U.S. IPO
03:05pm, Thursday, 23'rd Jul 2020
Freeline Therapeutics Holdings has filed to float its stock in a U.S. IPO.
BioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 1-Year High at $131.50
07:50am, Wednesday, 22'nd Jul 2020
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as $131.50 and last traded at $131.02, with a volume
Redpoint Investment Management Pty Ltd Has $611,000 Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
06:56am, Wednesday, 22'nd Jul 2020
Redpoint Investment Management Pty Ltd grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 31.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchan
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
BioMarin to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 4 at 4:30pm ET
12:30pm, Tuesday, 21'st Jul 2020
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, August 4,
